Author: MyHairline Editorial Team Editorial review: MyHairline medical content review. Named clinician reviewer pending verified reviewer relationship and crawlable bio. Last updated: May 2026
Educational use only. This article is not medical advice. The Myhairline.ai analyzer is an educational classification tool and does not diagnose, treat, or prescribe. Treatment decisions belong with a board-certified dermatologist or qualified clinician.
The $47-a-Month Question
Last March, a 29-year-old graphic designer named Marcus in Austin, Texas, sat on his couch toggling between two browser tabs: Hims on the left, Keeps on the right. His temples had been creeping back for about 18 months, somewhere around a Norwood 2.5 if you want to be precise about it. "I spent an embarrassing amount of time comparing these two," he told me. "Like, 45 minutes reading reviews. Then I realized I was basically comparison-shopping the same pill."
Marcus was right. And that realization is the most important thing you can take away from this entire article.
The Boring Truth About Identical Active Ingredients
Here's the thing: both Hims and Keeps sell FDA-approved generic finasteride and generic minoxidil. Same molecules. Same dosages. The finasteride is 1 mg oral, the same compound studied in the landmark 1998 trials by Kaufman et al. in the Journal of the American Academy of Dermatology, which showed significant hair count stabilization and modest regrowth versus placebo in men with androgenetic alopecia. The minoxidil is 5% topical, the concentration validated by Olsen et al. in their 2002 randomized clinical trial, also in the JAAD, which demonstrated clear superiority over 2% minoxidil and placebo.
You are not choosing between two treatments. You are choosing between two subscription wrappers around the same treatments.
That doesn't mean the comparison is pointless. It just means the comparison is about logistics, price, and user experience rather than pharmacology.
Where the Actual Differences Live
Strip away the branding and Instagram ads, and the real differentiators between Hims and Keeps boil down to a short list:
Monthly cost at standard dosing. Prices fluctuate with promotions, but both services price generic finasteride and generic minoxidil within a few dollars of each other. At the time of this writing, you can often find finasteride through either service for roughly $20 to $30 per month, though bundled plans shift those numbers. Generic finasteride at a retail pharmacy with a GoodRx coupon can run under $10. That gap is the convenience premium.
Telemedicine model. Both use asynchronous consultations, meaning you fill out a questionnaire, upload photos, and a licensed prescriber reviews your case without a live video visit. Neither is a deep clinical relationship. If your hair loss pattern is straightforward androgenetic alopecia, this is probably fine. If it's not straightforward (sudden diffuse shedding, patchy loss, scalp symptoms), you need an actual dermatologist, not either of these services.
Formulation variants. This is where minor differences emerge. Both companies have experimented with combination topical products (finasteride plus minoxidil in a single solution, for example) and different delivery formats. These compounded formulations don't have the same independent trial data as the individual FDA-approved ingredients. They may be convenient. They may work well. But the evidence base is thinner.
Customer experience and shipping. Read the subreddits. Some people swear by one service's packaging and cancel-flow simplicity; others have had billing headaches with the other. This is consumer-product territory, not medical territory, and your mileage will genuinely vary.
What the Trial Evidence Actually Supports
Since we're talking about the same active drugs, the evidence applies equally to both brands.
Finasteride (1 mg daily) remains the best-studied single oral agent for male androgenetic alopecia. The Kaufman et al. (1998) data, along with subsequent long-term follow-ups, showed hair count improvements sustained over multiple years in the majority of men treated. Side effects, particularly sexual side effects, occur in a small percentage of users, and the question of post-finasteride syndrome remains debated in the literature. This is a conversation for you and your prescriber, not something a subscription quiz can adequately address.
Minoxidil (5% topical) has strong trial support from Olsen et al. (2002) and decades of real-world use. Response rates vary. Some men see meaningful regrowth; many see stabilization; a subset see little change. It works better on the vertex than the hairline, and you have to keep using it or any gains reverse.
For anyone eyeing the laser caps or devices that both services occasionally bundle or upsell: the 2014 trial by Jimenez et al. in American Journal of Clinical Dermatology showed modest hair count improvements from low-level laser therapy compared with sham devices, but effect sizes were smaller than those seen with finasteride or minoxidil. Consumer-grade laser devices are FDA-cleared via the 510(k) pathway, which demonstrates substantial equivalence to a predicate device, not primary efficacy through rigorous Phase III trials the way drugs are approved. That doesn't mean they're useless. It means the evidence is lighter, and expectations should be proportional.
The Comparison Nobody Wants to Make
I think the most useful "him vs keeps" comparison isn't Hims versus Keeps at all. It's branded telehealth subscription versus walking into a retail pharmacy with a prescription from your own doctor.
If you have insurance, a dermatologist visit might cost a copay. Generic finasteride at a pharmacy can cost $8 to $15 per month. Generic minoxidil foam is available over the counter for less than either subscription charges. The total monthly outlay can be half or less than what you'd pay through either Hims or Keeps.
The subscription services earn their premium by removing friction. No scheduling a doctor visit, no driving to a pharmacy, no refill calls. For some people that friction removal is worth $15 to $20 a month. For others it's not. Neither choice is wrong.
Where this falls apart is when the subscription model substitutes for clinical judgment. Androgenetic alopecia is common, but it's not the only cause of hair loss in young men. Telogen effluvium, alopecia areata, thyroid disorders, nutritional deficiencies, scarring alopecias: these require proper diagnosis, not a questionnaire. If your pattern doesn't look like classic male pattern baldness (progressive temple recession, vertex thinning, as classified by Hamilton in 1951 and refined by Norwood in 1975), get evaluated in person.
How "Best" Lists Distort the Picture
Most "him vs keeps" comparison articles you'll find online carry affiliate links. The article gets paid when you click through and subscribe. That doesn't automatically make the information wrong, but it creates a structural incentive to recommend both products enthusiastically and to avoid the less exciting conclusion, which is: these are interchangeable for most people.
The dermatology literature doesn't care which brand ships your finasteride. It cares about whether you're on the right medication, at the right dose, for the right diagnosis, with appropriate monitoring. The most expensive branded subscription and the cheapest generic pharmacy fill produce identical blood levels of the same drug.
Before-and-after photos on either company's site are marketing materials, not clinical evidence. They're selected for dramatic results, often with uncontrolled lighting and styling differences, and they tell you nothing about the probability of a similar outcome for your specific head.
So Who Should Pick Which?
For Marcus in Austin, the decision came down to whichever service offered a better introductory price that month. He ended up with Keeps, tried it for six months, then switched to picking up generic finasteride at his local CVS when he realized the medication was identical and cheaper. "I'm grateful the subscription got me started," he said. "But once you know what you're taking, you don't need the fancy box."
That's roughly the recommendation I'd give most people: if the convenience of a telehealth subscription lowers the activation energy enough to get you started on an evidence-backed treatment, it's money well spent for a few months. Long term, you can almost certainly find the same medications for less through a pharmacy. And regardless of how you access the medication, a baseline evaluation with a board-certified dermatologist is worth the single visit, if only to confirm you're actually dealing with androgenetic alopecia and not something else.
Common Questions
Are branded telemedicine services more effective than generic medication? For FDA-approved medications, the active ingredient is identical regardless of brand. Differences between services are in pricing, formulation options, and the clinical oversight model, not in the drug itself.
Which has stronger evidence, a device or a medication? For androgenetic alopecia, finasteride and minoxidil have substantially more replicated trial evidence than any laser device. Low-level laser therapy has trial-level support (Jimenez et al., 2014), but effect sizes are smaller and the research base is less extensive.
Does the Myhairline.ai analyzer diagnose hair loss? No. The analyzer is an educational classification tool. It does not diagnose, treat, or prescribe. A clinical diagnosis of any hair loss condition requires examination by a board-certified dermatologist.
Can I use both finasteride and minoxidil together? Many dermatologists do recommend combination therapy. The mechanisms are different (finasteride blocks DHT; minoxidil promotes blood flow to follicles), so they can be complementary. Discuss this with your prescriber.
Are the treatment outcomes discussed here guaranteed? No. Every treatment discussed has documented variability in outcome across patients. No medication, device, or procedure guarantees regrowth, and no responsible clinician or article should claim otherwise.
Is one subscription easier to cancel than the other? Both services have been criticized at various points for making cancellation less straightforward than sign-up. Check current cancellation policies before subscribing, and consider setting a calendar reminder to review your subscription every few months.
Continue Reading
This article is part of the Comparisons & Decision-Making cluster on Myhairline.ai. The pillar overview is The Norwood Scale: Complete Guide to Male Pattern Hair Loss Stages, and the cluster hub is Comparisons & Decision-Making Cluster Hub.
Within this cluster:
- Diffuse Thinning Vs Male Pattern Baldness: a focused reference on diffuse thinning vs male pattern baldness.
- Keeps Vs Hims: a focused reference on keeps vs hims.
- Capillus Vs Irestore: a focused reference on capillus vs irestore.
Related from other clusters:
- What are good alternatives for micro pigment scalp treatment?: a focused reference on what are good alternatives for micro pigment scalp treatment. (from the Non-Surgical Treatments cluster).
- Hair Transplant Cost Mexico - Real Numbers: a focused reference on hair transplant cost mexico. (from the Hair Transplant Cost & Process cluster).
Key References
Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology. 1998;39(4):578-589.
Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology. 2002;47(3):377-385.
Jimenez JJ, Wikramanayake TC, Bergfeld W, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss. American Journal of Clinical Dermatology. 2014;15(2):115-127.
Hamilton JB. Patterned loss of hair in man: types and incidence. Annals of the New York Academy of Sciences. 1951;53(3):708-728.
Norwood OT. Male pattern baldness: classification and incidence. Southern Medical Journal. 1975;68(11):1359-1365.